Deerfield Management Company, L.P. (Series C) Biogen Inc. Call Options Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

Call Options

1 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $93.8 Million - $112 Million	500,000 New	500,000 $102 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.44 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.39 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.13 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.08 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$752 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account